Matruseva Superspeciality Center Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.77 Cr
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth 31.30%
- Profit Growth 180.24%
- Ebitda 8.96%
- Net Worth 11.75%
- Total Assets -0.64%
About Matruseva Superspeciality Center
Matruseva Superspeciality Center Private Limited (MSCPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 December 2016 (Eight years and one month 16 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.77 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amruta Patil, Ashok Patil, Keval Patil, and Three other members serve as directors at the Company.
Company Details
-
Location
Sangli, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85190PN2016PTC167495
-
Company No.
167495
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Dec 2016
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Matruseva Superspeciality Center?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amruta Patil
|
Director | 14-Dec-2016 | Current |
|
Ashok Patil
|
Director | 14-Dec-2016 | Current |
|
Keval Patil
|
Director | 14-Dec-2016 | Current |
|
Nikhil Patil
|
Director | 14-Dec-2016 | Current |
|
Vidula Patil
|
Director | 14-Dec-2016 | Current |
|
Priyanka Patil
|
Director | 14-Dec-2016 | Current |
Financial Performance of Matruseva Superspeciality Center.
Matruseva Superspeciality Center Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.3% increase. The company also saw a substantial improvement in profitability, with a 180.24% increase in profit. The company's net worth Soared by an impressive increase of 11.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Matruseva Superspeciality Center?
In 2019, Matruseva Superspeciality Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹27.70 M
₹20.00 M
Charges Breakdown by Lending Institutions
- Others : 2.77 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2023 | Others | ₹2.70 M | Open |
| 09 Mar 2017 | Others | ₹2.50 Cr | Open |
| 26 Sep 2018 | Others | ₹2.00 Cr | Satisfied |
How Many Employees Work at Matruseva Superspeciality Center?
Unlock and access historical data on people associated with Matruseva Superspeciality Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Matruseva Superspeciality Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Matruseva Superspeciality Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.